Detailed information for compound 330975

Basic information

Technical information
  • TDR Targets ID: 330975
  • Name: 6-chloro-N-cyclobutyl-7-fluoro-1,1-dioxo-4H-b enzo[e][1,2,4]thiadiazin-3-amine
  • MW: 303.74 | Formula: C11H11ClFN3O2S
  • H donors: 2 H acceptors: 2 LogP: 1.85 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1cc2NC(=NS(=O)(=O)c2cc1F)NC1CCC1
  • InChi: 1S/C11H11ClFN3O2S/c12-7-4-9-10(5-8(7)13)19(17,18)16-11(15-9)14-6-2-1-3-6/h4-6H,1-3H2,(H2,14,15,16)
  • InChiKey: MJTBWTMVMIWVJP-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • (6-chloro-7-fluoro-1,1-diketo-4H-benzo[e][1,2,4]thiadiazin-3-yl)-cyclobutyl-amine
  • BPDZ-256

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus granulosus Basic leucine zipper bZIP transcription factor 0.0188 0.038 0.0535
Schistosoma mansoni hypothetical protein 0.0155 0.0119 1
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription factor 0.0188 0.038 0.0535
Echinococcus multilocularis nuclear factor of activated T cells 5 0.1024 0.7111 1
Onchocerca volvulus 0.1382 1 0.5
Schistosoma mansoni jun-related protein 0.0155 0.0119 1
Schistosoma mansoni retinoblastoma-binding protein 4 (rbbp4) 0.0141 0.0007 0.0604
Loa Loa (eye worm) hypothetical protein 0.1382 1 1
Echinococcus granulosus jun protein 0.0188 0.038 0.0535
Loa Loa (eye worm) hypothetical protein 0.0168 0.0225 0.0218
Echinococcus multilocularis Ankyrin 0.0141 0.0007 0.001
Brugia malayi bZIP transcription factor family protein 0.0188 0.038 0.038
Echinococcus granulosus nuclear factor of activated T cells 5 0.1024 0.7111 1
Echinococcus granulosus Ankyrin 0.0141 0.0007 0.001
Echinococcus multilocularis jun protein 0.0188 0.038 0.0535

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) = 39.9 uM Concentration required to relax KCl induced rat aorta ring contractions by 50% upon incubation with the compound at 37 degree C for 90 mins ChEMBL. 16033278
IC50 (functional) = 0.23 uM Concentration required to inhibit insulin release in rat pancreatic islets by 50% upon incubation with the compound at 37 degree C for 90 mins ChEMBL. 16033278
Release (functional) = 12.8 % Percent residual insulin release in rat pancreatic islets upon incubation with the compound (10 uM) at 37 degree C for 90 mins ChEMBL. 16033278
Release (functional) = 15.3 % Percent residual insulin release in rat pancreatic islets upon incubation with the compound (1 uM) at 37 degree C for 90 mins ChEMBL. 16033278
Release (functional) = 74.5 % Percent residual insulin release in rat pancreatic islets upon incubation with the compound (0.1 uM) at 37 degree C for 90 mins ChEMBL. 16033278
Selectivity (functional) = 173.5 Ratio of EC50 required to relax KCl induced rat aorta ring contractions to that of IC50 required to inhibit insulin release in rat pancreatic islets ChEMBL. 16033278

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.